Abstract
The oligopeptidase B serine protease is an important virulence factor and therapeutic target in Trypanosoma infections. Recently, the Leishmania major Genome Project identified a new oligopeptidase B that was denominated oligopeptidase B-like, herein named oligopeptidase B-2. In this study, a complete open reading frame of oligopeptidase B-2 from Leishmania amazonensis (PH8 strain) was amplified by PCR using primers designed for the oligopeptidase B-2 gene of L. major. The 2,715 bp fragment coded for a protein of 905 amino acids with a predicted molecular mass of 103,918.9 Da and theoretical pI of 5.82. The encoded protein displayed ∼96% identity with L. major and ∼75% identity with Trypanosoma cruzi and T. brucei oligopeptidases B-2, and ∼21% identity with Escherichia coli and L. amazonensis classical oligopeptidase B. An unusual C-terminal extension was found in relation to the classical trypanosomatid oligopeptidase B. By sequence alignment, we determined a catalytic triad (Ser 629, Asp 717 and His 758), S1 subsite (Glu 674 and Glu 676) and suggest a difference in the S2 subsite of L. amazonensis oligopeptidase B-2. We also found that the oligopeptidase B-2 gene is expressed in all cycle stages of L. amazonensis. A phylogenetic analysis indicated that oligopeptidase B-2 is a new member of oligopeptidase B.
[1] Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. 1997. Gapped BLAST and PSIBLAST: A new generation of protein database search programs. Nucleic Acids Research, 25, 3389–3402. http://dx.doi.org/10.1093/nar/25.17.338910.1093/nar/25.17.3389Search in Google Scholar
[2] Alves C.R., Benevolo-De-Andrade T.C., Alves J.L., Pirmez C. 2004. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis. Parasite Immunology, 26, 127–135. DOI: 10.1111/j.0141-9838.2004.00691.x. http://dx.doi.org/10.1111/j.0141-9838.2004.00691.x10.1111/j.0141-9838.2004.00691.xSearch in Google Scholar
[3] Alves C.R., Corte-Real S., Bourguignon S.C., Chaves C.S., Saraiva E.M. 2005. Leishmania amazonensis: Early proteinase activities during promastigote-amastigote differentiation in vitro. Experimental Parasitology, 109, 38–48. DOI: 10.1016/j.exppara.2004.10.005. http://dx.doi.org/10.1016/j.exppara.2004.10.00510.1016/j.exppara.2004.10.005Search in Google Scholar
[4] Azeredo-Coutinho R.B., Conceicao-Silva F., Schubach A., Cupolillo E., Quintella L.P., Madeira M.F., Pacheco R.S., Valete-Rosalino C.M., Mendonca S.C. 2007. First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, 735–737. DOI: 10.1016/j.trstmh.2007.01.005. http://dx.doi.org/10.1016/j.trstmh.2007.01.00510.1016/j.trstmh.2007.01.005Search in Google Scholar
[5] Barral A., Pedral-Sampaio D., Grimaldi G. Jr., Momen H., McMahon-Pratt D., Ribeiro de Jesus A., Almeida R., Badaro R., Barral-Netto M., Carvalho E.M. 1991. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. American Journal of Tropical Medicine and Hygiene, 44, 536–546. Search in Google Scholar
[6] Becker M.M., Harrop S.A., Dalton J.P., Kalinna B.H., McManus D.P., Brindley P.J. 1995. Cloning and characterization of the Schistosoma japonicum aspartic proteinase involved in hemoglobin degradation. Journal of Biological Chemistry, 270, 24496–24501. http://dx.doi.org/10.1074/jbc.270.41.2449610.1074/jbc.270.41.24496Search in Google Scholar
[7] Burleigh B.A., Woolsey A.M. 2002. Cell signalling and Trypanosoma cruzi invasion. Cellular Microbiology, 4, 701–711. DOI: 10.1046/j.1462-5822.2002.00226.x. http://dx.doi.org/10.1046/j.1462-5822.2002.00226.x10.1046/j.1462-5822.2002.00226.xSearch in Google Scholar
[8] Cazzulo J.J. 2002. Proteinases of Trypanosoma cruzi: Potential targets for the chemotherapy of Chagas disease. Current Topics in Medicinal Chemistry, 2, 1261–1271. DOI: 10.2174/1568 026023392995. http://dx.doi.org/10.2174/156802602339299510.2174/1568026023392995Search in Google Scholar
[9] Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R.W., Alvar J., Boelaert M. 2007. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Reviews Microbiology, 5, 873–882. DOI: 10.1038/ nrmicro1748. http://dx.doi.org/10.1038/nrmicro174810.1038/nrmicro1748Search in Google Scholar
[10] Dávila A.M.R. 2002. Tripanosomose animal na América do Sul: Epizootiologia, Evolução e Tecnologias da Informação. Tese de doutorado. Fiocruz, RJ. Search in Google Scholar
[11] Gasteiger E., Hoogland C., Gattiker A., Duvaud S., Wilkins M.R., Appel R.D., Bairoch A. 2005. Protein Identification and Analysis Tools on the ExPASy Server. In: (Ed. J.M. Walker) The Proteomics Protocols Handbook. Humana Press, 571–607. Search in Google Scholar
[12] Gerczei T., Keseru G.M., Naray-Szabo G. 2000. Construction of a 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes. Journal of Molecular Graphics and Modelling, 18, 7–17. DOI: 10.1016/S1093-3263(99)00042-X. http://dx.doi.org/10.1016/S1093-3263(99)00042-X10.1016/S1093-3263(99)00042-XSearch in Google Scholar
[13] Guedes H.L.M., Carneiro M.P.D., Gomes D.C.O., Rossi-Bergmann B., De-Simone S.G. 2007. Oligopeptidase B from L. amazonensis: Molecular cloning, gene expression analysis and molecular model. Parasitology Research, 101, 865–875. DOI: 10.1007/s00436-007-0630-8. http://dx.doi.org/10.1007/s00436-007-0630-810.1007/s00436-007-0630-8Search in Google Scholar PubMed
[14] Huang X., Miller W. 1991. A time-efficient, linear-space local similarity algorithm. Advances in Applied Mathematics, 12, 337–357. DOI: 10.1016/0196-8858(91)90017-D. http://dx.doi.org/10.1016/0196-8858(91)90017-D10.1016/0196-8858(91)90017-DSearch in Google Scholar
[15] Ivens A.C., Peacock C.S., Worthey E.A., Murphy L., Aggarwal G., Berriman M., et al. 2005. The genome of the kinetoplastid parasite, Leishmania major. Science, 309, 436–442. DOI: 10.1126/science.1112680. http://dx.doi.org/10.1126/science.111268010.1126/science.1112680Search in Google Scholar
[16] Kumar S., Tamura K., Nei M. 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Briefings in Bioinformatics, 5, 150–163. DOI: 10.1093/bib/5.2.150. http://dx.doi.org/10.1093/bib/5.2.15010.1093/bib/5.2.150Search in Google Scholar
[17] Mishra J., Saxena A., Singh S. 2007. Chemotherapy of leishmaniasis: past, present and future. Current Medicinal Chemistry, 14, 1153–1169. DOI: 10.2174/092986707780362862. http://dx.doi.org/10.2174/09298670778036286210.2174/092986707780362862Search in Google Scholar
[18] Morty R.E., Fulop V., Andrews N.W. 2002. Substrate recognition properties of oligopeptidase B from Salmonella enterica serovar Typhimurium. Journal of Bacteriology, 184, 3329–3337. DOI: 10.1128/JB.184.12.3329-3337.2002. http://dx.doi.org/10.1128/JB.184.12.3329-3337.200210.1128/JB.184.12.3329-3337.2002Search in Google Scholar
[19] Morty R.E., Lonsdale-Eccles J.D., Morehead J., Caler E.V., Mentele R., Auerswald E.A., Coetzer T.H., Andrews N.W., Burleigh B.A. 1999. Oligopeptidase B from Trypanosoma brucei, a new member of an emerging subgroup of serine oligopeptidase. Journal of Biological Chemistry, 274, 26149–26156. http://dx.doi.org/10.1074/jbc.274.37.2614910.1074/jbc.274.37.26149Search in Google Scholar
[20] Morty R.E., Pelle R., Vadasz I., Uzcanga G.L., Seeger W., Bubis J. 2005. Oligopeptidase B from Trypanosoma evansi. A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts. Journal of Biological Chemistry, 280, 10925–10937. DOI: 10.1074/jbc.M410066200. http://dx.doi.org/10.1074/jbc.M41006620010.1074/jbc.M410066200Search in Google Scholar
[21] Morty R.E., Troeberg L., Pike R.N., Jones R., Nickel P., Lonsdale-Eccles J.D., Coetzer T.H.T. 1998. Trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin. FEBS Letters, 433, 251–256. http://dx.doi.org/10.1016/S0014-5793(98)00914-410.1016/S0014-5793(98)00914-4Search in Google Scholar
[22] Mottram J.C., North M.J., Barry J.D., Coombs G.H. 1989. Acysteine proteinase cDNA from Trypanosoma brucei predicts an enzyme with an unusual C-terminal extension. FEBS Letters, 258, 211–215. http://dx.doi.org/10.1016/0014-5793(89)81655-210.1016/0014-5793(89)81655-2Search in Google Scholar
[23] Notredame C., Higgins D.G., Heringa J. 2000. T-Coffee: A novel method for fast and accurate multiple sequence alignment. Journal of Molecular Biology, 302, 205–217. http://dx.doi.org/10.1006/jmbi.2000.404210.1006/jmbi.2000.4042Search in Google Scholar PubMed
[24] Polgar L. 2002. The prolyl oligopeptidase family. Cellular and Molecular Life Sciences, 59, 349–362. DOI: 10.1007/s00018-002-8427-5. http://dx.doi.org/10.1007/s00018-002-8427-510.1007/s00018-002-8427-5Search in Google Scholar
[25] Sadij M., McKerrow J.H. 2002. Cysteine proteases of parasitic organisms. Molecular and Biochemical Parasitology, 120, 1–21. DOI: 10.1016/S0166-6851(01)00438-8. http://dx.doi.org/10.1016/S0166-6851(01)00438-810.1016/S0166-6851(01)00438-8Search in Google Scholar
[26] Sambrook J., Russell D.W. 2001. Molecular cloning: A laboratory manual. Third edition. CSH Press, 1–33. Search in Google Scholar
[27] Shaw J. 2007. The leishmaniases — survival and expansion in a changing world. A mini-review. Memórias do Instituto Oswaldo Cruz, 102, 541–547. http://dx.doi.org/10.1590/S0074-0276200700050000110.1590/S0074-02762007000500001Search in Google Scholar
[28] Spath G.F., Beverley S.M. 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Experimental Parasitology, 99, 97–103. DOI: 10.1006/expr.2001.4656. http://dx.doi.org/10.1006/expr.2001.465610.1006/expr.2001.4656Search in Google Scholar PubMed
[29] Thompson J.D., Higgins D.G., Gibson T.J. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research, 22, 4673–4680. DOI: 10.1093/nar/22.22.4673. http://dx.doi.org/10.1093/nar/22.22.467310.1093/nar/22.22.4673Search in Google Scholar PubMed PubMed Central
[30] Tolezano J.E., Uliana S.R.B., Taniguchi H.H., Araujo M.F.L., Barbosa J.A.R., Barbosa J.E.R., Floeter-Winter L.M., Shaw J.J. 2007. The first records of Leishmania (Leishmania) amazonensis in dogs (Canis familiaris) diagnosed clinically as having canine visceral leishmaniasis from Araçatuba County, Sao Paulo State, Brazil. Veterinary Parasitology, 149, 280–284. DOI: 10.1016/j.vetpar.2007.07.008. http://dx.doi.org/10.1016/j.vetpar.2007.07.00810.1016/j.vetpar.2007.07.008Search in Google Scholar PubMed
[31] Vermelho A.B., De-Simone S.G., d’Avila-Levy C.M., do Santos A.L.S., de Melo A.C.N., Silva F.P.Jr., Bon E.P.S., Branquinha M.H. 2007. Trypanosomatidae peptidases: A target for drugs development. Current Enzyme Inhibition, 3, 319–348. http://dx.doi.org/10.2174/15734080777981546810.2174/157340807779815468Search in Google Scholar
[32] Williams R.A., Kelly S.M., Mottram J.C., Coombs G.H. 2003. 3-Mercaptopyruvate sulfurtransferase of Leishmania contains an unusual C-terminal extension and is involved in thioredoxin and antioxidant metabolism. Journal of Biological Chemistry, 278, 1480–1486. DOI: 10.1074/jbc.M209395200. http://dx.doi.org/10.1074/jbc.M20939520010.1074/jbc.M209395200Search in Google Scholar PubMed
[33] Wong J.Y, Harrop S.A., Day S.R., Brindley P.J. 1997. Schistosomes express two forms of cathepsin D. Biochimica et Biophysica Acta, 1338, 156–160. Search in Google Scholar
© 2008 W. Stefański Institute of Parasitology, PAS
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.